Reimbursement & Pricing,

20.07.2020

DiGA consultation: prescription and use

BfArM has held consultation meetings with about 50 DiGA manufacturers and received 14 applications for inclusion in the DiGA directory (as of 7/16/20). By the end of August, the first DiGAs listed in the directory and eligible for prescription are expected. For the time being, prescribing will be done via sample 16; the basis for use and billing will be a 16-digit prescription code. Price negotiations will take place between the manufacturer and the GKV-SV after successful evaluation. Relevant principles on pricing and reimbursement are regulated in the framework agreement and billing guideline.

Read the full article here (in German) or contact us for the article in English and more information how to support your clients when facing regress. 

Reimbursement & Pricing,

02.09.2019 

Regresses -  Rather a perceived threat to the physician, but still a serious obstacle for pharmaceutical companies

Whether justified or not, the fear of regresses of physicians is immense. Whether the probability of regresses is low, the extent of damage can be great from a physician’s point of view. Many physicians are already afraid of the conspicuity itself.

Read the full article here (in German) or contact us for the article in English and more information how to support your clients when facing regress. 

Reimbursement & Pricing,

05.10.2017

Mental illness - huge boosts for demand for smart case management!

According to a report by the Federal Statistical Office (Destatis) from 29. September 2017, the healthcare costs for mental and behavioural disorders went up to 44.4 billion Euro, constituting the second biggest share of the total health care expenditure of 338.2 billion Euro. Mental illness has never been such a big issue as it is today. A recent study by the AOK-Bundesverband, which was presented in a press release on 14. September 2017, states that medical certificates (sick leave) due to mental problems have increased by 79.3 percent over the past ten years, resulting in 25.7 days of workplace absence on average. The loss of gross value added due to mental illness was estimated to amount to 16.8 billion in 2015 by the Federal Office for Occupational Safety and Health. Wittchen and Jacobi (2013) from Robert-Koch-Institute in Berlin report that about one third of the population suffers from one or more mental disorders per year.

Read the full article here (in German) or contact us for the article in English and more information about case management programs for mental illness patients.